Leukemia Therapeutics Market 2019 by Trends, Segments, Size, Insights and Forecast upto 2023
Mar 5, 2019
Global leukemia therapeutics market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 10.7 billion in 2017 and is projected to grow at a CAGR of 5.3% over the forecast period.
Pune, India - March 5, 2019 /MarketersMedia/ —
Leukemia is blood cancer which most commonly in adults and children. Acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia are the major types of the leukemia. leukemia therapeutics are used in treating the leukemia.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/7425
The factors such as innovative therapies to drive the market for leukemia, increase prevalence of leukemia, and increasing older population are expected to propel the growth of the market. However, high cost required for the development of new therapeutics hamper the market growth over the forecast period.
Global leukemia therapeutics market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 10.7 billion in 2017 and is projected to grow at a CAGR of 5.3% over the forecast period.
Segmentation
The global leukemia therapeutics market has been segmented into type, applications, and region.
Based on type, leukemia therapeutics market is segmented into chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant. The chemotherapy segment is expected to account for the largest share segment of the market in 2017. Chemotherapy segment further sub segmented into alkylating agents, antimetabolites, antitumor antibiotics, and others.
Based on applications, leukemia therapeutics market is segmented into acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, and others.
The leukemia therapeutics market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The leukemia therapeutics market in the Americas further segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European leukemia therapeutics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The leukemia therapeutics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The leukemia therapeutics market in the Middle East & Africa segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global leukemia therapeutics market owing to a well-established player, innovative therapies to drive the market for leukemia, increase prevalence of leukemia, and increasing older population.
Europe is expected to hold the second largest position in the global leukemia therapeutics market. The market growth in this region is attributed to increase prevalence of leukemia.
The leukemia therapeutics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.
The Middle East & Africa has the least share of the leukemia therapeutics market.
Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/leukemia-therapeutics-market-7425
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Contact Us:, Market Research Future, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar,, Pune - 411028, Maharashtra, India, Phone: +1 646 845 9312, Email: [email protected]
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/leukemia-therapeutics-market-7425
Source: MarketersMedia
Release ID: 488591
More News
One EV sold every 100 seconds: More electric cars to hit Australia’s roads
Cheaper models and soaring fuel prices have supercharged Australia’s electric vehicle sales and triggered a decisive tipping point for the industry.
Housing, fuel drive higher inflation; banks fall, Northern Star gains
The Australian sharemarket opened little changed on Wednesday, as traders digest the RBA’s move to lift interest rates to a 15-year high.
Trump rejects AI laws after tech titans agree to ‘self-police’ AI development
The US president shot down the idea of new regulations for AI, but signed an accord with top tech executives setting a “morally binding” set of voluntary safety commitments.
Anthropic warns investors its AI could pose ‘existential risks to humanity’
In the prospectus for its $US2 trillion sharemarket float, the company uses 80 pages to outline its AI models’ dangers, including unpredictable behaviours such as attempts to “resist shutdown” and “conceal or manipulate information.”
Asking for free dental care is like pulling teeth. But we still need to do it
I’m far from the only one delaying treatment. Like my wisdom tooth, though, the cost of keeping dental care unaffordable will probably only grow.
From fear to greed and back again: AI is taking Wall Street to extremes
Artificial intelligence could wipe us all out. Or it might just kill our unwanted subscriptions. Those are the scenarios sharemarkets have swung between over the past two weeks.
ASX edges higher after RBA boss tempers Cup day rate hike fears
The Australian market was initially down in the mid-afternoon, when the central bank flagged it was willing to inflict more pain on home owners if needed.
Rio2 gold ramp-up rebounds from Chilean winter blast
Rio2 Ltd has resumed gold production ramp-up at its Fenix Gold mine in Chile after winter storms halted progress, with commercial production still on track for the fourth quarter.
Critica surges after unveiling $1.4B tin-tungsten prize in Tasmania
Critica Ltd surged after a scoping study at its Tasmanian tin-tungsten project delivered a $1.42B pre-tax NPV, 65% IRR and 1.9-year payback from a proposed underground mine.
TikTok and Meta ran hundreds of ads for illegal tobacco, vapes
The ads, many of which have since been pulled, helped to fuel a mammoth black market that has spawned firebombings and crime around the country.
Accelerate grabs full control of Pilbara manganese play
Accelerate Resources has taken 100 per cent ownership of its Woodie Woodie North manganese project in WA, issuing shares to remove all future milestone payments and royalties.
Mortgage calculator: Here’s how much extra your repayments will be
The RBA has increased interest rates to 4.60 per cent. Use our calculator to see how much extra your mortgage repayments will be.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.